Nanoparticles for Drug Delivery

Recorded webinar

Nanoparticles have unique properties that are manipulated to create novel solutions, with its most significant contribution in the field of drug delivery. Nanoparticles are usually defined as a particle of matter in the range of 1 – 100 nm.. One of the major fields of nanotechnology research is the application of nanoparticles used for drug delivery, with considerable research and development devoted to this field. Because nanoparticle size and surface properties are critical physical parameters influencing behavior, proper particle size analysis is essential in both research and development, and ultimately in quality control. Dynamic light scattering (DLS) is the most frequented analytical method to perform these measurements.

In this webinar, we will discuss:

  • Nanoparticle definitions
  • Effect of size on water solubility
  • Nanoparticle drugs on the market
  • Controlled release qualities
  • Doxorubicin examples
  • Low concentration measurements
  • Online size monitoring

About the Presenter:

Mark Bumiller | Entegris Technology Manager


Mark has worked in the field of particle size analysis for over 35 years. Positions held include product manager at Hiac Royco (5 years), technical support manager and vice president of business development at Malvern Instruments (17 years), vice president of particle products at Horiba (6 years) and technology manager at Particle Sizing Systems, LLC, and now Entegris (6 years).

He has served as a member of the expert committee for USP
<788>, the executive committee of the International Fine Particle Research Institute (IFPRI), and the executive committee of Particle Technology Forum of the American Institute of Chemical Engineers.

Mark is an active member of Technical Committee 24 within ISO helping to write standards for particle size and zeta potential analysis. His B.S. in chemical engineering was earned at Carnegie Mellon University in Pittsburgh, PA.